Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Sepsis Diagnostics Market Revenue Growth Supported By A CAGR Of 1.56% Through 2030
The market for sepsis diagnostics has demonstrated robust expansion lately, with a projected increase from $1.07 billion in 2025 to $1.16 billion in 2026, reflecting a compound annual growth rate of 8.3%. This upward trajectory historically has been fueled by a confluence of factors, including the increasing incidence of hospital-acquired infections, the wider adoption of rapid diagnostic testing methodologies, the reception of regulatory approvals for new technologies, enhancements in laboratory infrastructure, and a growing level of clinical awareness regarding sepsis.
The market for sepsis diagnostics is poised for substantial expansion in the coming years, projected to reach $1.57 billion by 2030, fueled by a compound annual growth rate of 7.9%. This anticipated growth trajectory is primarily driven by advancements such as AI-powered diagnostic solutions, the increasing adoption of biomarker-based testing methodologies, the seamless integration of tele-diagnostic services, the development of innovative sepsis detection assays, and the burgeoning field of point-of-care diagnostics. Key developments expected to shape the market during this forecast period encompass the proliferation of point-of-care diagnostic devices, the growing utilization of biomarker-based tests, the introduction of rapid blood culture kits, the increasing deployment of AI-assisted diagnostic platforms, and enhanced integration with existing hospital information technology systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp
Sepsis Diagnostics Market Opportunity Drivers: What Is Creating New Revenue Potential?
The increasing prevalence of infections contracted within healthcare settings is anticipated to be a key driver for the expansion of the sepsis diagnostics market. These hospital-acquired infections, commonly referred to as HAIs, manifest during or subsequent to a patient’s admission to a medical facility, usually appearing at least 48 hours after being admitted, and were not present upon initial entry. This upward trend in HAIs is largely attributed to the growing problem of antibiotic resistance. The widespread and often improper use of antibiotics within the healthcare system has facilitated the evolution of bacteria that are no longer susceptible to these treatments, thereby complicating the management of infections. Sepsis diagnostics play a crucial role in the early identification of hospital-acquired infections by pinpointing specific pathogens and relevant biomarkers, which in turn facilitates prompt medical intervention and mitigates potential adverse outcomes. Illustrating this point, data from November 2024, as reported by the Australian Institute of Health and Welfare, a governmental body in Australia, indicated that for the 2022–23 period, hospital-acquired complications (HACs) were recorded in 2% of admissions to public hospitals and 0.8% of admissions to private hospitals, with infections acquired during healthcare representing the most common complication. Consequently, the escalating rate of hospital-acquired infections serves as a significant impetus for the growth observed in the sepsis diagnostics market.
Sepsis Diagnostics Market Segment Analysis And Revenue Opportunities
The sepsis diagnostics market covered in this report is segmented –
1) By Product: Instruments, Blood Culture Media, Assay Kits And Reagents, Software
2) By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Other Technologies
3) By Pathogen: Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens
4) By Method: Automated Diagnostics, Conventional Diagnostics
5) By End-Users: Hospitals And Clinics, Pathology And Reference Laboratories, Research Institutes
Subsegments:
1) By Instruments: Automated Analyzers, Point-Of-Care (PoC) Testing Devices, Microfluidic-Based Devices, Polymerase Chain Reaction (PCR) Instruments, Flow Cytometers
2) By Blood Culture Media: Aerobic Blood Culture Media, Anaerobic Blood Culture Media, Mycobacteria Blood Culture Media, Pediatric Blood Culture Media, Fungal Blood Culture Media
3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Polymerase Chain Reaction (PCR) Assay Kits, Immunoassay Reagents, Molecular Diagnostic Reagents, Biosensor-Based Assay Kits
4) By Software: Data Management Software, Laboratory Information Systems (LIS), Artificial Intelligence (AI)-Based Diagnostic Tools, Predictive Analytics Software, Cloud-Based Diagnostic Platforms
Sepsis Diagnostics Market Innovation Trends Driving Future Development
Within the sepsis diagnostics arena, leading entities are concentrating on the creation of novel approaches, notably culture-free diagnostic methods, aimed at facilitating swift and precise sepsis identification, thereby circumventing reliance on conventional blood cultures. A culture-free diagnostic approach represents a means to identify infectious agents or diseases without employing standard microbial cultivation processes. These innovative solutions leverage sophisticated technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassay techniques to quickly pinpoint pathogens directly from clinical specimens like blood, saliva, or tissue. Exemplifying this trend, in April of 2024, Deepull Diagnostics S.L., a manufacturing firm situated in Spain, introduced its UllCORE diagnostic system, designed for the early detection of sepsis. The UllCORE system functions as a compact, culture-free multiplex PCR platform, engineered by Deepull to expedite pathogen identification in cases of sepsis and other acute infections. This system is capable of extracting microbial DNA from 8 mL of whole blood and delivers 50 reportable findings within a single hour. It possesses the capability to identify 95% of pathogens responsible for sepsis, encompassing bacteria, fungi, and genes associated with antibiotic resistance. Developed with the dual purpose of enhancing early diagnosis and minimizing inappropriate antibiotic use, the UllCORE system serves as a valuable asset for healthcare facilities engaged in the fight against antimicrobial resistance.
Sepsis Diagnostics Market Leading Players Shaping Industry Direction
Major companies operating in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMérieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., EKF Diagnostics Holdings plc, Boditech Med Inc., Alifax S.r.l., Abionic SA
Access The Complete Sepsis Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report
Sepsis Diagnostics Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the sepsis diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model